Nowadays, it seems like CBD is everywhere. From cocktails, to dog treats, to vape pens, there is no shortage of ways to consume the magical medical marijuana derivative that lacks the psychoactive “high” associated with THC. However, a recent NBC News article says the FDA and FTC are cracking down on the medical claims made by companies that market CBD products. The agencies sent warning letters to three companies including Nutra Pure, PotNetwork Holdings, and Advanced Spine and Pain.
The letters claim the companies are falsely advertising the effectiveness of supplements to treat diseases including cancer, Alzheimer’s, fibromyalgia, and neuropsychiatric disorders. This marks the first time the FDA and FTC have issued a joint warning letter together. The companies that received warning letters have 15 days to notify the FTC of specific actions taken to address the concerns. The FDA said that it will hold its first public hearing on May 31st to explore how CBD can be used safely in food, supplements, and cosmetics.